MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

This compatibility recommendation is derived from Zestril 5mg tablets (Atnahs Pharma UK Ltd).

Provenance

This compatibility recommendation is derived from Zestril 5mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zestril 10mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zestril 20mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

Protect from moisture. Protect from light.

Provenance

This compatibility recommendation is derived from Prothiaden 75mg tablets (Teofarma S.r.l.).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Ezetrol 10mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd).

Stability Notes

Store in an airtight container. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Cymbalta 60mg gastro-resistant capsules (Eli Lilly and Company Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Lansoprazole 15mg gastro-resistant capsules (Accord Healthcare Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Lansoprazole 30mg gastro-resistant capsules (Accord Healthcare Ltd).

Stability Notes

Store in well-closed containers. Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Inegy 10mg/20mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

Store in well-closed containers. Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Inegy 10mg/40mg tablets (Organon Pharma (UK) Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.